Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | CNR1 | P21554 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 4/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.44 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.44 |
| ▸ | PLA2G4C | Q9UP65 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7570925 | 0.97 | S1PR1 (0.47) | ALDH1A1CNR1MAPTTHRBS1PR1 | |
| SCHEMBL18262003 | 0.94 | P2RY10 (0.44) | S1PR1TRPV1 | |
| SCHEMBL7571747 | 0.94 | P2RY10 (0.44) | S1PR1TRPV1 | |
| SCHEMBL969822 | 0.94 | P2RY10 (0.44) | S1PR1TRPV1 | |
| SCHEMBL7573946 | 0.91 | FABP3 (0.42) | ALDH1A1CNR1MAPTTHRBBLM | |
| SCHEMBL17144721 | 0.87 | PLA2G2C (0.43) | — | |
| SCHEMBL37519 | 0.87 | PLA2G2C (0.43) | — | |
| SCHEMBL19410782 | 0.87 | PLA2G2C (0.43) | — | |
| SCHEMBL226745 | 0.87 | PLA2G2C (0.43) | — | |
| SCHEMBL3963403 | 0.87 | PLA2G2C (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196931-A1 | CYCLIC LIPIDS AND LIPID NANOPARTICLES (LNP) FOR THE DELIVERY OF NUCLEIC ACIDS OR PEPTIDES FOR USE IN VACCINATING AGAINST INFECTIOUS AGENTS | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2023-10-12 | — | — | WO | disclosed |
| EP-3863645-A1 | MODIFIED MRNA FOR THE TREATMENT OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS DISORDERS | ModernaTX, Inc. (US) | 2021-08-18 | — | — | EP | disclosed |
| WO-2020056370-A1 | MODIFIED MRNA FOR THE TREATMENT OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS DISORDERS | MODERNATX, INC. (US) | 2020-03-19 | — | — | WO | disclosed |
| WO-2007053800-A2 | CHARGE-MODIFIED LYSOZYME ANTIMICROBIAL COMPOSITIONS, SURFACTANTS, AND METHODS FOR INFECTIONS AND CYSTIC FIBROSIS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2007-05-10 | — | — | WO | disclosed |
| EP-0845981-B1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORP (US) | 2002-09-25 | — | — | EP | disclosed |
| US-5935936-A | A DRUG DELIVERY FOR GENE THERAPY COMPRISING A DIAMINO-POLY-ALKYLAMINE-CARBAMOYL CHOLESTEROL AND AT LEAST ONE PHOSPHATIDES | GENZYME CORPORATION (US) | 1999-08-10 | — | — | US | disclosed |
| EP-0845981-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997046223-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1997-12-11 | — | — | WO | disclosed |